TherapeuticsMD, Inc. (TXMD)Healthcare | Drug Manufacturers - Specialty & Generic | Boca Raton, United States | NasdaqGS
2.18 USD
-0.01
(-0.457%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 2.18 Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:06 p.m. EDT
TherapeuticsMD (TXMD) is a polarizing small-cap biotech play: the fundamental balance sheet (healthy cash vs debt, nascent revenue growth) supports a speculative hold for strategic milestones, but the lack of dividends and negative operating margins make it a poor capital-efficient vehicle for conservators. The recent price surge and 5xx% surge in call volume at $3.0 strikes confirm that smart money is betting on a catalyst event (likely regulatory) to drive a 50%+ move, but the recent price action trading near the 50-day moving average suggests the rally may be running out of steam without new news. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.089938 |
| MSTL | 0.106549 |
| AutoTheta | 0.368591 |
| AutoARIMA | 0.468554 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 6.30 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.447 |
| Excess Kurtosis | -0.56 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 22.686 |
| Revenue per Share | 0.261 |
| Market Cap | 25,232,110 |
| Forward P/E | 6.23 |
| Beta | 0.56 |
| Profit Margins | -18.83% |
| Website | https://www.therapeuticsmd.com |
As of April 18, 2026, 11:06 p.m. EDT: Options activity reveals high call interest at OTM strikes (3.0 and 5.0) for mid-term and end-of-year expirations, indicating a speculative bullish thesis on regulatory developments. However, there is significant recent volume in OTM puts (strike 3.0) for the June expiration, which has added OI above floating volume, suggesting a sentiment hedge against the upside rally. The volatility surface is compressed (ATM IV ~4-6%), reflecting low expected movement but active positioning on high-conviction directional bets.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.972973 |
| Address1 | 951 Yamato Road |
| Address2 | Suite 220 |
| All Time High | 8,000.0 |
| All Time Low | 0.7 |
| Ask | 2.52 |
| Ask Size | 1 |
| Audit Risk | 7 |
| Average Daily Volume10 Day | 25,390 |
| Average Daily Volume3 Month | 40,324 |
| Average Volume | 40,324 |
| Average Volume10Days | 25,390 |
| Beta | 0.558 |
| Bid | 1.84 |
| Bid Size | 1 |
| Board Risk | 5 |
| Book Value | 2.322 |
| City | Boca Raton |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.18 |
| Current Ratio | 3.019 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 2.25 |
| Day Low | 2.09 |
| Debt To Equity | 22.686 |
| Display Name | TherapeuticsMD |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda | -1,983,000 |
| Ebitda Margins | -0.65619004 |
| Enterprise To Ebitda | -12.084 |
| Enterprise To Revenue | 7.929 |
| Enterprise Value | 23,961,852 |
| Eps Forward | 0.35 |
| Eps Trailing Twelve Months | -0.06 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.2128 |
| Fifty Day Average Change | -0.03279996 |
| Fifty Day Average Change Percent | -0.01482283 |
| Fifty Two Week Change Percent | 97.2973 |
| Fifty Two Week High | 2.95 |
| Fifty Two Week High Change | -0.77 |
| Fifty Two Week High Change Percent | -0.26101694 |
| Fifty Two Week Low | 0.98 |
| Fifty Two Week Low Change | 1.2 |
| Fifty Two Week Low Change Percent | 1.2244898 |
| Fifty Two Week Range | 0.98 - 2.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,178,717,400,000 |
| Float Shares | 9,559,266 |
| Forward Eps | 0.35 |
| Forward P E | 6.228572 |
| Free Cashflow | 303,625 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 1.0 |
| Gross Profits | 3,022,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.074499995 |
| Held Percent Institutions | 0.29253 |
| Implied Shares Outstanding | 11,574,362 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,652,054,400 |
| Last Split Factor | 1:50 |
| Long Business Summary | TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida. |
| Long Name | TherapeuticsMD, Inc. |
| Market | us_market |
| Market Cap | 25,232,110 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_114205175 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -653,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 25,347,852 |
| Open | 2.18 |
| Operating Cashflow | 2,424,000 |
| Operating Margins | -1.0851101 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 561 961 1900 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 2.18 |
| Post Market Time | 1,776,802,205 |
| Previous Close | 2.19 |
| Price Hint | 4 |
| Price To Book | 0.9388458 |
| Price To Sales Trailing12 Months | 8.349474 |
| Profit Margins | -0.18829 |
| Quick Ratio | 2.441 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.45662057 |
| Regular Market Day High | 2.25 |
| Regular Market Day Low | 2.09 |
| Regular Market Day Range | 2.09 - 2.25 |
| Regular Market Open | 2.18 |
| Regular Market Previous Close | 2.19 |
| Regular Market Price | 2.18 |
| Regular Market Time | 1,776,801,600 |
| Regular Market Volume | 34,736 |
| Return On Assets | -0.03869 |
| Return On Equity | -0.02408 |
| Revenue Growth | 0.339 |
| Revenue Per Share | 0.261 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 2 |
| Shares Outstanding | 11,574,362 |
| Shares Percent Shares Out | 0.0042 |
| Shares Short | 48,285 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 45,159 |
| Short Name | TherapeuticsMD, Inc. |
| Short Percent Of Float | 0.0058 |
| Short Ratio | 2.17 |
| Source Interval | 15 |
| State | FL |
| Symbol | TXMD |
| Total Cash | 7,483,000 |
| Total Cash Per Share | 0.647 |
| Total Debt | 6,097,000 |
| Total Revenue | 3,022,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.6305 |
| Two Hundred Day Average Change | 0.5495001 |
| Two Hundred Day Average Change Percent | 0.33701327 |
| Type Disp | Equity |
| Volume | 34,736 |
| Website | https://www.therapeuticsmd.com |
| Zip | 33,431 |